Expand GLSI Menu
GLSI MENU

GLSI Latest Press Releases

-- January 22, 2026 --

Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01 Globe Newswire 6:00 AM

-- December 29, 2025 --

Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026 Globe Newswire 6:00 AM

-- December 22, 2025 --

Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy Globe Newswire 6:00 AM

-- December 15, 2025 --

Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01 Globe Newswire 6:00 AM

-- December 8, 2025 --

Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01 Globe Newswire 6:00 AM

-- December 3, 2025 --

Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date Globe Newswire 6:00 AM

-- October 9, 2025 --

Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial Globe Newswire 6:00 AM

-- October 2, 2025 --

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium Globe Newswire 6:00 AM

-- September 30, 2025 --

Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial Globe Newswire 6:00 AM

-- September 18, 2025 --

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland Globe Newswire 6:00 AM

-- September 10, 2025 --

Greenwich LifeSciences' GLSI-100 Granted US FDA Fast Track Designation Globe Newswire 6:00 AM
Market Data Delayed 15 Minutes